Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | USFD | CW |
|---|---|---|
| Price | $92.92 | $538.15 |
| Change today | ▲ 0.77% | ▼ 1.04% |
| Market cap | $20.10B | $19.88B |
| Return, 3 months | -8.8% | -28.9% |
| Return, year to date | +23.4% | -2.3% |
| Return, 1 year | +23.4% | -0.6% |
| P/E (TTM) | 28.6 | 37.0 |
| P/B | 4.7 | 7.2 |
| P/E percentile vs own 5y | 26th | 73rd |
| Dividend yield | – | 0.18% |
| Revenue growth (YoY, latest qtr) | +4.5% | +5.4% |
| Net profit growth (YoY) | +22.8% | +24.9% |
| Gross margin | 17.6% | 37.7% |
| Operating margin | 3.2% | 18.9% |
| Net margin | 1.8% | 14.8% |
| Return on equity | 16.4% | 19.7% |
| Analyst target vs. price | +24.5% | +41.7% |
| Analyst buy share | 78% | 67% |
| RSI (14) | 29 | 33 |
| 30-day volatility | 22.5% | 25.6% |
| Max drawdown, 1 year | -21.1% | -32.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
